Table 4.
Adverse events.
Control (n = 16) | Foralumab/Dexa (N = 11) | Foralumab (n = 12) | ||
---|---|---|---|---|
Headache | 1 | 0 | 3 | |
Burning in the nostril | 0 | 0 | 1 | |
Retrosternal pain | 0 | 2 | 0 | |
Pustular Lesions and Itching in cervical area | 0 | 0 | 1 | |
Dysuria | 1 | 0 | 0 | |
Tachycardia (anxiety) | 0 | 1 | 0 | |
Insomnia | 0 | 0 | 1 |
The incidence and severity of adverse events was determined according to the National Cancer Institute Common Terminology Criteria for Adverse Events, version 5.0. Dexa= Dexamethasone.